{"id":299343,"date":"2019-10-21T20:00:17","date_gmt":"2019-10-22T03:00:17","guid":{"rendered":"https:\/\/nai500.com\/?p=299343"},"modified":"2019-10-21T20:00:46","modified_gmt":"2019-10-22T03:00:46","slug":"exegenesis-bio-%e4%bb%8e%e4%b8%ad%e5%9b%bd%e6%8a%95%e8%b5%84%e8%80%85%e8%8e%b7%e5%be%97%e5%8d%83%e4%b8%87%e7%be%8e%e5%85%83%e8%9e%8d%e8%b5%84","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/10\/exegenesis-bio-%e4%bb%8e%e4%b8%ad%e5%9b%bd%e6%8a%95%e8%b5%84%e8%80%85%e8%8e%b7%e5%be%97%e5%8d%83%e4%b8%87%e7%be%8e%e5%85%83%e8%9e%8d%e8%b5%84\/","title":{"rendered":"\u57fa\u56e0\u6cbb\u7597\u516c\u53f8Exegenesis Bio\u4ece\u4e2d\u56fd\u6295\u8d44\u8005\u83b7\u5f97\u5343\u4e07\u7f8e\u5143\u878d\u8d44"},"content":{"rendered":"<p>\u8d39\u57ce\u57fa\u56e0\u6cbb\u7597\u516c\u53f8Exegenesis Bio\u4ece\u4e2d\u56fd\u6295\u8d44\u8005\u83b7\u5f971000\u4e07\u7f8e\u5143\u878d\u8d44\uff0c\u7531\u9669\u5cf0\u65d7\u4e91\u9886\u6295\uff0c\u51ef\u6cf0\u8d44\u672c\u548c\u8054\u60f3\u4e4b\u661f\u8ddf\u6295\u3002Exegenesis Bio\u6b63\u5728\u5f00\u53d1\u5c1a\u672a\u6ee1\u8db3\u9700\u6c42\u7684\u8d1f\u62c5\u5f97\u8d77\u7684\u4e00\u6d41\u57fa\u56e0\u7597\u6cd5\uff0c\u5e76\u5c06\u5728\u4e2d\u56fd\u548c\u5168\u7403\u9500\u552e\u3002Exegenesis Bio\u7684\u7ba1\u7406\u56e2\u961f\u5e73\u5747\u62e5\u670915\u5e74\u7684\u7ec6\u80de\u548c\u57fa\u56e0\u7597\u6cd5\u7ecf\u9a8c\u3002Exegenesis Bio\u7684\u521b\u59cb\u4eba\u517c\u9996\u5e2d\u6267\u884c\u5b98Zhenhua Wu\u535a\u58eb\u66fe\u5728\u8d39\u57ce\u5730\u533a\u7684\u591a\u5bb6\u521b\u65b0\u751f\u7269\u5236\u836f\u516c\u53f8\u4ee5\u53ca\u845b\u5170\u7d20\u53f2\u514b\u548c\u9ed8\u514b\u516c\u53f8\u4efb\u804c\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aChina Biotoday<\/p>\n<div id=\"gtx-trans\">\n<div class=\"gtx-trans-icon\"><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Exegenesis Bio, a Philadelphia gene therapy company, raised over $10 million in initial funding from China investors, K2VC, Kaitai Capital and Lenovo Star. The company is developing affordable first-in-class and best-in-class gene therapies for high unmet needs, which it will market in China and globally. <\/p>\n","protected":false},"author":9,"featured_media":299340,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-299343","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/299343","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=299343"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/299343\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/299340"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=299343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=299343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=299343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}